Sumitomo Pharma Co., Ltd. (DNPUF)
16.74
0.00 (0.00%)
USD |
OTCM |
Dec 10, 16:00
Sumitomo Pharma Total Assets (Quarterly): 5.271B for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 97.98B |
| Nxera Pharma Co., Ltd. | 976.25M |
| PeptiDream Inc. | 525.27M |
| Stemcell Holdings, Inc. | -- |
| Healios KK | 117.32M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 3.472B |
| Shareholders Equity (Quarterly) | 1.798B |
| Debt to Equity Ratio | 0.9897 |
| Current Ratio | 1.362 |
| Net Debt Paydown Yield | 2.80% |